Exact Mass: 308.1291476
Exact Mass Matches: 308.1291476
Found 500 metabolites which its exact mass value is equals to given mass value 308.1291476,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phenylbutazone
A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822) M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3615 EAWAG_UCHEM_ID 3615; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1158 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Cornexistin
Monocerin
A natural product found in Colletotrichum species.
C.I. Solvent Red 80
Colourant for orange skins. Allowed on fruit which is not to be processed. Use prohibited in orange peel for human consumption. Colourant for orange skins. Allowed on fruit which is not to be processed. Use prohibited in orange peel for human consumption
DMXB-A
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
8-Acetylegelolide
8-Acetylegelolide is found in herbs and spices. 8-Acetylegelolide is a constituent of Achillea millefolium (yarrow). Constituent of Achillea millefolium (yarrow). 8-Acetylegelolide is found in herbs and spices.
Azacridone A
Azacridone A is found in citrus. Azacridone A is an alkaloid from roots of Citrus paradisi (grapefruit). Alkaloid from roots of Citrus paradisi (grapefruit). Azacridone A is found in citrus.
2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium
2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium is a maillard product from reaction of L-proline and 2-Furancarboxaldehyde
Mono-(2-ethyl-5-carboxypentyl) phthalate
Mono-(2-ethyl-5-carboxypentyl) phthalate is also known as 2-ethyl-5-carboxypentyl phthalate, MECPP or phthalate, mono(5-carboxy-2-ethylpentyl) ester. It is classified as a member of the benzoic acid esters. Benzoic acid esters are ester derivatives of benzoic acid. Mono-(2-ethyl-5-carboxypentyl) phthalate is considered to be practically insoluble (in water) and acidic. (ChemoSummarizer). It is a metabolite of mono(2-ethylhexyl) phthalate (MEHP) and a secondary metabolite of di(2-ethylhexyl) phthalate (DEHP).
2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline
C19H20N2S (308.13471200000004)
4-Butyl-5-hydroxy-1,2-diphenylpyrazol-3-one
Delpazolid
3-(2,4-Dimethoxybenzylidene)anabaseine
5'-N-Ethylcarboxamidoadenosine
Penilloic acid
2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol
C16H16N6O (308.13855259999997)
Linomide
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C1971 - Angiogenesis Activator Inhibitor L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D007155 - Immunologic Factors
Toddaline
Toddalolactone is a natural product found in Zanthoxylum asiaticum with data available. Toddalolactone, a main component of Toddalia asiatica, inhibits the activity of recombinant human plasminogen activator inhibitor-1 (PAI-1), with an IC50 value of 37.31 μM[1]. Toddalolactone, a main component of Toddalia asiatica, inhibits the activity of recombinant human plasminogen activator inhibitor-1 (PAI-1), with an IC50 value of 37.31 μM[1].
Toddalolactone
Toddalolactone is a natural product found in Zanthoxylum asiaticum with data available. Toddalolactone, a main component of Toddalia asiatica, inhibits the activity of recombinant human plasminogen activator inhibitor-1 (PAI-1), with an IC50 value of 37.31 μM[1]. Toddalolactone, a main component of Toddalia asiatica, inhibits the activity of recombinant human plasminogen activator inhibitor-1 (PAI-1), with an IC50 value of 37.31 μM[1].
2,4-Dihydroxy-3-(1,1-dimethyl-2-propenyl)chalcone
1-Acetonyl-7-carboxyl-6,8-dihydroxy-3,4,5-trimethylisochroman
nifenazone
C17H16N4O2 (308.12731959999996)
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BB - Pyrazolones C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
NAPHTHO(1,8-bc)PYRAN-7,8-DIONE, 6,9-DIMETHYL-3-(4-METHYL-3-PENTENYL)-
1beta-acetonyl-7-carboxyl-6,8-dihydroxy-3alpha,4beta,5-trimethylisochroman
(2-Methyl-2-propyl-propan-1,3-diol)-D(?)-glucuronid|<2-Methyl-2-propyl-propan-1,3-diol>-D(?)-glucuronid
Asnipyrone B
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1E,3E,5E stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
Benzyl glycoside,2,3-O-isopropylidene,Me ester-beta-D-Furanose-Riburonic acid
4-Methylbenzenesulfonyl-3,3-Dimethylbicyclo[2.2.1]heptane-2-methanol
C17H24O3S (308.14460740000004)
methyl (3S,5S)-5-hydroxy-3-(beta-D-glucopyranosyl)-hexanoate
pantocin A
A member of the class of indolizines that is 3,5,6,7-tetrahydroindolizine which carries a 2-aminoacyl-4-amino-4-oxobutanoic acid, oxo, amino groups at positions 3S, 5 and 6S, respectively. It is a ribosomally encoded and post-translationally modified peptide natural product found in several species of the Pantoea genus and derived from a Glu-Glu-Asn precursor peptide.
(3Z,11Z,13E,7S*,9S*,10R*)-9-acetoxy-6-chloro-7:10-epoxypentadeca-3,11,13-trien-1-yne
C17H21ClO3 (308.11791460000006)
5-Hydroxyasperentin
A member of the class of isocoumarins that is asperentin substituted by an additional hydroxy group at position 5. It has been isolated from Chaetomium globosum and Aspergillus flavus.
Multiorthoquinone
A diterpenoid that is phenanthrene-3,4-dione substituted by a methoxy group at position 6, a methyl groups at positions 7 and 8 and an isopropyl group at position 2. A norabietane derivative, it is isolated from Salvia multicaulis and exhibits antitubercular activity.
12b-hydroxydecahydro-3aH-[1]benzofuro[3a,4-b]furo[2,3-g][1]benzofuran-5,7(2H,4H)-dione|incarviditone
Mexoticin
8-[(2R)-2,3-dihydroxy-3-methylbutyl]-5,7-dimethoxychromen-2-one is a natural product found in Murraya alata, Murraya caloxylon, and other organisms with data available.
3-Acetamido-3-deoxyadenosin|3-acetylamino-3-deoxy-adenosine
(2E,8Z)-decadiene-4,6-diyn-1-ol-1-O-beta-D-glucopyranoside
5-(3,3-dimethylallyloxy)-2-methoxycarbonyl-3-methoxy-4-methylbenzoic acid
18-hydroxy nor fluorocurarine|18-Hydroxynorfluorocurarine|strychnofluorine (18-hydroxynorfluorocurarine)
(20alpha)-20-methyl-15,16-didehydro-18-oxayohimban-21-one|Latifoliamide C
(E)-9-(4-hydroxy-3-methylbut-2-en-1-yl)phenazine-1-carboxylic acid|endophenazine A1
6R-[(5S,6S-diacetoxy)-1Z,3E-heptenyl]-5,6-dihydro-2H-pyran-2-one
(E)-6-(3-hydroxy-3-methylbut-1-en-1-yl)phenazine-1-carboxylic acid|endophenazine G
Isobutyric acid 2-methoxy-4-[3-(acetoxymethyl)oxiranyl]phenyl ester
(2S)-5-hydroxy-2-(cis-1,4-dihydroxycyclohexyl)-7-methoxychroman-4-one|(2S)-cis-4-hydroxy-ongokein
6-(3-Hydroxy-3-methyl-1-butenyl)-1-phenazinecarboxylic acid
4-methoxymagnaldehyde B|5-allyl-2-hydroxyphenyl-4-methoxy-3-cinnamic aldehyde
4-hydroxy-2,2-dimethyl-pyranoflavan|4-hydroxy-7,8-(2,2-dimethylpyran)flavan
(5Z,6R)-1,6,7,8-tetrahydro-5-(hydroxyethylidene)-7-methylene-2H-3,6-ethanoazonino[5,4-b]indol-4(5H)-one|pericidine
4a,7,7a,11,11a,13,14,14a-octahydro-7a,14a-dihydroxydibenzo[b,g][1,6]dioxecine-3,10(4H,6H)-dione|clerodenone A
3-Methylene-4-(1-hydroxy-3-oxobutyl)-5-(2-methyl-3-methoxy-5-oxo-1-cyclopentenyl)tetrahydrofuran-2-one
methyl gamma-methyl-delta-hydroxy-pentanoic acid beta-D-glucopyranoside
5-Allyl-2-(4-methoxyphenyl)-7-methoxy-3-methylbenzofuran
(E)-2-(4-methoxyphenyl)-7-methoxy-3-methyl-5-(prop-1-en-1-yl)benzofuran|eupomatenoid 16|eupomatenoid-16
7-ethoxy-7H,14H-phthalazino[2,3-b]phthalazine-5,12-dione|7-Ethoxyphthalazino<2,3-b>-phthalazin-5,12(7H,14H)dion|phthalazino(2,3-b) phthalazine-7-ethoxy-5,12-dione
Alpinoid D
Alpinoid D is a natural product found in Alpinia officinarum with data available.
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]pyridine-3-carboxamide
4-[3,5-dihydroxy-4-(2-methyl-1-oxopropyl)phenoxy]-2-methyl-2-butenoic acid methyl ester
2,4-dihydroxy-3-(3-methylbut-2-enyl)chalcone|Flemistricin-A|Flemistrictin|Iso-cordoin|Isocordoin
(E)-1-(L-cystein-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine
2H-1-Benzopyran-2-one, 6-[(1R,2S)-2,3-dihydroxy-1-methoxy-3-methylbutyl]-7-methoxy-
phenylbutazone
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1H-(Indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline
5,13,15-trihydroxy-9-methyl-10-oxabicyclo[10.4.0]hexadeca-1(12),13,15-triene-3,11-dione
3-(2,4-dihydroxypentyl)-6,8-dimethoxyisochromen-1-one
C16H20O6_1H-2-Benzopyran-6-acetic acid, 8a-ethenyloctahydro-5,7-dihydroxy-alpha,4-bis(methylene)-3-oxo-, methyl ester, (4aR,5R,6R,7S,8aR)
C16H20O6_1H-2-Benzoxacyclododecin-1,9(10H)-dione, 3,4,5,6,7,8-hexahydro-7,12,14-trihydroxy-3-methyl
C16H20O6_2H-3-Benzoxacyclododecin-2,10(1H)-dione, 4,5,6,7,8,9-hexahydro-8,11,13-trihydroxy-4-methyl
5,13,15-trihydroxy-9-methyl-10-oxabicyclo[10.4.0]hexadeca-1(12),13,15-triene-3,11-dione
methyl 2-[(4aR,5R,6R,7S,8aR)-8a-ethenyl-5,7-dihydroxy-4-methylidene-3-oxo-1,4a,5,6,7,8-hexahydroisochromen-6-yl]prop-2-enoate
Vincanidine
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Annotation level-1
(11S,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo(9.5.2.0(1,9).0(2,7).0(14,17))octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; Origin: Plant; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids PRIME in-house No.:V0312; Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids
3-(2,4-dihydroxypentyl)-6,8-dimethoxyisochromen-1-one [IIN-based: Match]
3-(2,4-dihydroxypentyl)-6,8-dimethoxyisochromen-1-one [IIN-based on: CCMSLIB00000847759]
UK-156819
CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4744; ORIGINAL_PRECURSOR_SCAN_NO 4743 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3450; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3446; ORIGINAL_PRECURSOR_SCAN_NO 3443 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3439; ORIGINAL_PRECURSOR_SCAN_NO 3437 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3452; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4773; ORIGINAL_PRECURSOR_SCAN_NO 4772 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7655; ORIGINAL_PRECURSOR_SCAN_NO 7653 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7663; ORIGINAL_PRECURSOR_SCAN_NO 7661 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7644; ORIGINAL_PRECURSOR_SCAN_NO 7642 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7660; ORIGINAL_PRECURSOR_SCAN_NO 7658 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7675; ORIGINAL_PRECURSOR_SCAN_NO 7673 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7714; ORIGINAL_PRECURSOR_SCAN_NO 7712
5-(2-Carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienal (2-carboxypyrrolidine)imine
3-Oxaachillicin
Methyl 2-[(4aR,5R,6R,7S,8aR)-5,7-dihydroxy-4-methylene-3-oxo-8a-vinyloctahydro-1H-isochromen-6-yl]acrylate
1,3-diisocyanato-2-methylbenzene,3-(3-hydroxypropoxy)propan-1-ol
furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol,propane-1,2-diol
8-chloro-2,3,4,4a,5,9b-hexahydro-1h-pyrido[4,3-b]indole
4-[5-(4-DIMETHYLAMINOPHENYL)OXAZOL-2-YL]BENZENEBORONIC ACID 97
9-benzyl-3,9-diazaspiro[5.5]undecane-2,4-dione (Hydrochloride)
3-(4-OXO-3-P-TOLYL-3,4-DIHYDRO-QUINAZOLIN-2-YL)-PROPIONIC ACID
1H-Benzimidazole,1-ethyl-2-[4-(methylsulfonyl)-1-piperazinyl]-(9CI)
BENZYL 5-METHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLATE
ethyl 2-[4-(3-amino-4-nitrophenyl)piperazin-1-yl]acetate
C14H20N4O4 (308.14844800000003)
(S)-tert-Butyl 3-(2-nitrophenoxy)pyrrolidine-1-carboxylate
N-(2-chloro-6-((trimethylsilyl)ethynyl)pyridin-3-yl)pivalamide
ETHYL 4-(2-METHYL-4-OXOQUINAZOLIN-3(4H)-YL)BENZOATE
tert-Butyl 4-(5-nitropyridin-2-yl)piperazine-1-carboxylate
C14H20N4O4 (308.14844800000003)
diethyl 2-acetamido-2-(pyridin-4-ylmethyl)propanedioate
tert-Butyl 4-(3-nitro-2-pyridyl)piperazine-1-carboxylate
C14H20N4O4 (308.14844800000003)
2,4-dihydro-4-[(2-methoxyphenyl)azo]-5-methyl-2-phenyl-3H-Pyrazol-3-one
C17H16N4O2 (308.12731959999996)
5-CHLORO-1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE
2-(3-CHLORO-5-(CYCLOPROPYLMETHOXY)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
C16H22BClO3 (308.13504420000004)
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-1-[tris(1-methylethyl)silyl]-
(6aR)-1,2,3,8,9-pentadeuterio-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,hydrochloride
C17H13ClD5NO2 (308.13398569000003)
1H-Pyrrolo[2,3-b]pyridine, 6-chloro-1-[tris(1-methylethyl)silyl]
5-N-Ethylcarboxamidoadenosine
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents 5'-N-Ethylcarboxamidoadenosine (NECA) is a nonselective adenosine receptor agonist. 5'-N-Ethylcarboxamidoadenosine (NECA) is a nonselective adenosine receptor agonist.
2-trans-benzoyl-5-trans-phenyl-1-cyclohexanecarboxylic acid
8-Benzyl-2-methyl-2,8-diazaspiro[4.5]decane-1,3-dione hydrochlori de (1:1)
1-Naphthalenecarboxaldehyde,2-(1-naphthalenylmethylene)hydrazone
3-[2-[(Trimethylsilyl)oxy]phenyl]acrylic acid trimethylsilyl ester
1,3-diisocyanato-2-methylbenzene,2-ethyl-2-(hydroxymethyl)propane-1,3-diol
PP242
C16H16N6O (308.13855259999997)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM[1]. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively[2]. Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM[1]. PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM, respectively[2].
3-O,5-O-Benzylidene-1-O,2-O-isopropylidene-α-D-glucofuranose
(3S)-3-tert-butoxycarbonylamino-1-nitro-2-oxo-4-phenylbutane
8-chloro-1,3,4,4a,5,9b-hexahydro-pyrido[4,3-b]indole-2-carboxylic acid tert-butyl ester
Delpazolid
D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride
C16H21ClN2S (308.11138960000005)
TERT-BUTYL 3-(2-NITROPHENOXY)PYRROLIDINE-1-CARBOXYLATE
ethyl 3,6-diphenyl-1H-1,2,4,5-tetrazine-2-carboxylate
C17H16N4O2 (308.12731959999996)
3-chloro-6-[4-(piperidin-1-ylcarbonyl)piperidin-1-yl]pyridazine
4-(6-Nitro-3-pyridinyl)-1-piperazinecarboxylic acid tert-butyl ester
C14H20N4O4 (308.14844800000003)
2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline
C19H20N2S (308.13471200000004)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
Penilloic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Nigerapyrone F
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1E,3E,5Z stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
Nigerapyrone H
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1Z,3E,5E stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
Nigerapyrone G
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl group at position 6 (the 1E,3Z,5E stereoisomer). It has been isolated from an endophytic fungus Aspergillus niger.
3-[(2,5-dimethylanilino)methyl]-6-methoxy-1H-quinolin-2-one
Benzylpenilloic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
N-(9beta-D-2-Deoxyribofuranosylpurin-6-yl)glycinamide
2-(2,3-dioxo-1-indolyl)-N-(2-phenylethyl)acetamide
2-[(2E)-2-(2,5-dimethylbenzylidene)hydrazinyl]-3-hydroxyquinazolin-4(3H)-one
C17H16N4O2 (308.12731959999996)
Mono[2-(carboxymethyl)hexyl] Phthalate
A phthalic acid monoester resulting from the formal condensation of one of the carboxy gruops of phthalic acid with the hydroxy group of 3-(hydroxymethyl)heptanoic acid.
2,5-Diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone
C14H20N4O4 (308.14844800000003)
3-(1,3-benzodioxol-5-ylmethyl)-4,10-dihydro-2H-[1,3,5]triazino[1,2-a]benzimidazole
C17H16N4O2 (308.12731959999996)
1-(5-Oxo-2,3,5,9b-tetrahydro-1h-pyrrolo[2,1-a]isoindol-9-yl)-3-pyridin-2-yl-urea
C17H16N4O2 (308.12731959999996)
Roquinimex
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C1971 - Angiogenesis Activator Inhibitor L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D007155 - Immunologic Factors
Methyl 2-(8a-ethenyl-5,7-dihydroxy-4-methylidene-3-oxo-1,4a,5,6,7,8-hexahydroisochromen-6-yl)prop-2-enoate
12-Ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
2-Amino-6-[3-(3,4-dihydroxyphenyl)prop-2-enoylamino]hexanoic acid
9,13,15-Trihydroxy-5-methyl-4-oxabicyclo[10.4.0]hexadeca-1(12),13,15-triene-3,11-dione
(1R,11S,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
7-(3-Amino-5-hydroxyphenyl)-7-hydroxy-2,6-dimethyl-3,5-dioxoheptanoate
(2R)-2-amino-3-[(E)-N-hydroxy-C-(7-methylsulfanylheptyl)carbonimidoyl]sulfanylpropanoic acid
Monodictysin C
A member of the class of xanthones that is 1,2,3,4,4a,9a-hexahydro-9H-xanthen-9-one substituted by hydroxy groups at positions 1, 4 and 8, methyl groups at positions 3 and 4a and a methoxy group at position 6 (the 1S,3S,4S,4aS,9aS stereoisomer). Isolated from the marine algicolous fungus Monodictys putredinis, it exhibits antineoplastic activity.
botryosphaerin H
A tetracyclic diterpenoid that is decahydro-4H,9H-[2]benzofuro[7,1-fg]isochromene-4,9-dionewhich is substituted by methyl groups at the 3a and 10b positions and by hydroxy groups at the 6 and 6a positions. A tetranorlabdane diterpenoid isolated from isolated from the solid fermentation products of Botryosphaeria sp. P483 that exhibits antifungal activity.
N-tert-butyl-2-[2-(3-nitrobenzoyl)hydrazinyl]-2-oxoacetamide
N-(3-acetylphenyl)-5,7-dimethyl-3-pyrazolo[1,5-a]pyrimidinecarboxamide
C17H16N4O2 (308.12731959999996)
N-(2-ethylphenyl)-5-(3-hydroxyphenyl)-1,2-oxazole-3-carboxamide
1-(4-Ethoxyphenyl)-3-(6-quinoxalinyl)urea
C17H16N4O2 (308.12731959999996)
5-Methyl-1-phenyl-4-pyrazolecarboxylic acid (4-methoxyphenyl) ester
N-[2-(6,7-dimethyl-2-oxo-1H-quinolin-3-yl)ethyl]ethanesulfonamide
N-(3-acetylphenyl)-5,7-dimethyl-2-pyrazolo[1,5-a]pyrimidinecarboxamide
C17H16N4O2 (308.12731959999996)
N-[2-(3-acetamidophenyl)-3H-benzimidazol-5-yl]acetamide
C17H16N4O2 (308.12731959999996)
4-[[(4-Hydroxy-1-piperidinyl)-sulfanylidenemethyl]amino]benzoic acid ethyl ester
N-cyano-N-(2-fluorophenyl)carbamimidothioic acid [2-(tert-butylamino)-2-oxoethyl] ester
C14H17FN4OS (308.11070440000003)
(2S,3R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxy-2-oxolanecarboxamide
3-(2,4-Dihydroxypentyl)-6,8-dimethoxyisochromen-1-one
2-[(2R,5R,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2R,5R,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5R,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5R,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2R,5S,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5S,6R)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2S,5S,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
2-[(2R,5S,6S)-5-[[anilino(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetic acid
N(2)-{[(3S,6S)-6-amino-5-oxo-3,5,6,7-tetrahydroindolizin-3-yl]carbonyl}-L-asparagine
3-amino-7-(4-methylpiperazin-1-yl)-9-oxo-9H-imidazo[1,2-a]indole-2-carbonitrile
C16H16N6O (308.13855259999997)
1-(1H-indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
(1R,11R,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
Cinnamic acid, p-(trimethylsiloxy)-, trimethylsilyl ester
(12Z)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
beta-(Trimethylsilyl)oxy-cinnamic acid trimethylsilyl ester
6-Acetoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-2-ethane-1-thiol
C17H24O3S (308.14460740000004)
10-[2-(4-Hydroxyphenyl)ethylamino]-7-aza-2-azoniatricyclo[6.3.1.04,12]dodeca-1(11),2,4(12),7,9-pentaen-11-ol
3-(2,4-Dimethoxybenzylidene)anabaseine
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxy-2-oxolanecarboxamide
2-Carboxy-1-[5-(2-carboxy-1-pyrrolidinyl)-2-hydroxy-2,4-pentadienylidene]pyrrolidinium
N(6)-carbamoylmethyl-2-deoxyadenosine
A nucleoside analogue that is adenosine in which one of the exocyclic amino hydrogens is replaced by a carbamoylmethyl group.
3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine
An O-glycosyl-L-serine having N-acetyl-beta-D-glucosaminyl as the glycosyl component.
O-(N-acetyl-alpha-D-galactosaminyl)-L-serine
A non-proteinogenic L-amino acid that is N-acetyl-alpha-D-galactosamine linked via an alpha glycosidic bond to the O at position 3 of L-serine.
14-Dihydroxycornestin
A cyclic dicarboxylic anhydride that is 5,6,7,8,9,10-hexahydro-1H-cyclonona[c]furan-1,3(4H)-dione substituted by an ethylidene group at position 9, hydroxy groups at position 5 and 8, a propyl group at position 4 and an oxo group at position 6.
SB-203186 (hydrochloride)
SB-203186 hydrochloride is a potent, selective and competitive 5-HT4 antagonist. SB-203186 hydrochloride antagonizes the 5-HT4 receptor-mediated relaxations of the carbachol-contracted rat isolated oesophagus against 5-HT with pKB values of 10.9 (rat oesophagus), 9.5 (guinea-pig ileum), and 9.0 (human colon) respectively[1][2][3].
2-[(2,2-dimethylchromen-6-yl)oxy]-5-(hydroxymethyl)oxolane-3,4-diol
(3r)-6,8-dihydroxy-3-{[(2r,5r,6s)-5-hydroxy-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
(5r,6s,7ar,8r,8ar)-8-acetyl-5,7a-dihydroxy-6-methoxy-3,5-dimethyl-6h,7h,8h,8ah-indeno[5,6-b]furan-2-one
(5s)-3-hydroxy-5-[(2r)-1-(5-hydroxy-3-methyl-4-oxo-5h-furan-2-yl)propan-2-yl]-4-methyl-5-[(1e)-prop-1-en-1-yl]furan-2-one
(2s,3r,5r)-5-[(1r,3z)-1-chlorohex-3-en-5-yn-1-yl]-2-[(1z,3e)-penta-1,3-dien-1-yl]oxolan-3-yl acetate
C17H21ClO3 (308.11791460000006)
3,10-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h,4ah,10h,10ah-naphtho[2,3-c]pyran-5-one
(3z,8r,11z,16r)-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone
methyl (3r,5r,7r,8s)-3,11-dihydroxy-7,8,10-trimethyl-2,6-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),9,11-triene-3-carboxylate
9-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]phenazine-1-carboxylic acid
5,14-dihydroxy-2,11-dioxatricyclo[12.4.0.0⁵,¹⁰]octadeca-6,15-diene-8,17-dione
methyl 2-(8a-ethenyl-5,7-dihydroxy-4-methylidene-3-oxo-hexahydro-2-benzopyran-6-yl)prop-2-enoate
(4br,10ar)-9-hydroxy-7-methoxy-11,11-dimethyl-4bh,10h,10ah-benzo[b]fluoren-5-one
(1r,3s,4s,8r,11r,12s,16r)-4-hydroxy-2,7,17-trioxapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadecane-10,14-dione
(3s,7e,8r)-7-ethylidene-5-methyl-5,12-diazatetracyclo[9.7.0.0³,⁸.0¹³,¹⁸]octadeca-1(11),13,15,17-tetraene-2,10-dione
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5s,6r)-4,5,6-trihydroxycyclohex-2-en-1-yl]oxy}oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1s,2r,5s,6s)-2,5,6-trihydroxycyclohex-3-en-1-yl]oxy}oxane-3,4,5-triol
(3ar,4s,7r,9r,9as,9bs)-4,7-dihydroxy-9-methoxy-6,9-dimethyl-3-methylidene-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2,8-dione
6-(acetyloxy)-3-hydroxy-1,4,5-trimethoxyhexan-2-yl acetate
2-(3,4-dimethoxyphenyl)-3-methyl-5-[(1e)-prop-1-en-1-yl]-1-benzofuran
(2r,4r,6r)-10-hydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
(3e,11e)-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,5,10,13-tetrone
3,5-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
3-[(2r,12bs)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-5h-furan-2-one
(2s)-cis-4'-hydroxy-ongokein
{"Ingredient_id": "HBIN006797","Ingredient_name": "(2s)-cis-4'-hydroxy-ongokein","Alias": "NA","Ingredient_formula": "C16H20O6","Ingredient_Smile": "COC1=CC(=C2C(=O)CC(OC2=C1)C3(CCC(CC3)O)O)O","Ingredient_weight": "308.33 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10553","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "76764418","DrugBank_id": "NA"}
(2s)-trans-4'-hydroxy-ongokein
{"Ingredient_id": "HBIN006826","Ingredient_name": "(2s)-trans-4'-hydroxy-ongokein","Alias": "NA","Ingredient_formula": "C16H20O6","Ingredient_Smile": "COC1=CC(=C2C(=O)CC(OC2=C1)C3(CCC(CC3)O)O)O","Ingredient_weight": "308.33 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10554","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "76764418","DrugBank_id": "NA"}
(1s,3s,4s,4ar,9as)-1,4,8,9a-tetrahydroxy-4a-(hydroxymethyl)-3-methyl-2,3,4,10-tetrahydro-1h-anthracen-9-one
16-methyl-15-oxa-1,11-diazapentacyclo[15.3.1.0⁴,¹².0⁵,¹⁰.0¹³,¹⁸]henicosa-4(12),5,7,9,13-pentaen-20-one
(15r,19r)-15-ethyl-1,11-diazapentacyclo[9.7.1.0²,⁷.0⁸,¹⁹.0¹⁵,¹⁹]nonadeca-2,4,6,8-tetraene-10,18-dione
(3,5-dihydroxy-2-{2-[(2s,6s)-6-methyloxan-2-yl]acetyl}phenyl)acetic acid
(2s,3r,4as,9as,10s)-2,3,5,10-tetrahydroxy-7-methoxy-2-methyl-1,3,4,4a,9a,10-hexahydroanthracen-9-one
8-(2,3-dihydroxy-3-methylbutyl)-5-hydroxy-7-methoxy-2-methylchromen-4-one
3-(2,4-dihydroxyheptyl)-6,8-dihydroxyisochromen-1-one
(5s)-3-hydroxy-5-[(2s)-1-(5-hydroxy-3-methyl-4-oxo-5h-furan-2-yl)propan-2-yl]-4-methyl-5-[(1e)-prop-1-en-1-yl]furan-2-one
(2s)-7-hydroxy-8-[(1e)-3-methylbut-1-en-1-yl]-2-phenyl-2,3-dihydro-1-benzopyran-4-one
methyl 2-{[8-hydroxy-6-(hydroxymethyl)-2,2-dimethyl-3,4-dihydro-1-benzopyran-3-yl]oxy}prop-2-enoate
12-ethyl-9-hydroxy-8,16-diazatetracyclo[10.6.1.0²,⁷.0¹⁶,¹⁹]nonadeca-1(19),2,4,6,8,17-hexaen-15-one
(2s,4r,6r)-10-hydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
2-[(2r)-2-[(acetyloxy)methyl]oxiran-2-yl]-5-(hydroxymethyl)phenyl 2-methylpropanoate
8,12-dimethyl-4-(4-methylpent-3-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,8-pentaene-10,11-dione
2,3,5,10-tetrahydroxy-7-methoxy-2-methyl-1,3,4,4a,9a,10-hexahydroanthracen-9-one
(3s,4ar,5r,10as)-3,5-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
2-(2-hydroxyethyl)-3,4-bis(hydroxymethyl)cyclopent-3-en-1-yl 4-hydroxybenzoate
8-(4-hydroxy-3-methylbutoxy)-5,7-dimethoxychromen-2-one
(4r,8s)-8,11,13-trihydroxy-4-methyl-4,5,6,7,8,9-hexahydro-1h-3-benzoxacyclododecine-2,10-dione
(4r,5s)-4-[(1r)-1-hydroxy-3-oxobutyl]-5-[(3s)-3-methoxy-2-methyl-5-oxocyclopent-1-en-1-yl]-3-methylideneoxolan-2-one
6-(acetyloxy)-4-hydroxy-1,3,5-trimethoxyhexan-2-yl acetate
(3s,4ar,5r,10as)-5,9-dihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
(1r,5r,10s,14r)-5,14-dihydroxy-2,11-dioxatricyclo[12.4.0.0⁵,¹⁰]octadeca-6,15-diene-8,17-dione
1,4,8-trihydroxy-6-methoxy-3,4a-dimethyl-2,3,4,9a-tetrahydro-1h-xanthen-9-one
{3,5-dihydroxy-2-[2-(6-methyloxan-2-yl)acetyl]phenyl}acetic acid
(2r,3s,5s)-5-[(3z)-1-chlorohex-3-en-5-yn-1-yl]-2-[(1z,3e)-penta-1,3-dien-1-yl]oxolan-3-yl acetate
C17H21ClO3 (308.11791460000006)
1,6,7,10-tetrahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
methyl (2e)-4-[3,5-dihydroxy-4-(2-methylpropanoyl)phenoxy]-2-methylbut-2-enoate
6,8-dihydroxy-3-[(4-hydroxy-6-methyloxan-2-yl)methyl]-3,4-dihydro-2-benzopyran-1-one
(3s,7s)-7,12,14-trihydroxy-3-methyl-4,5,6,7,8,10-hexahydro-3h-2-benzoxacyclododecine-1,9-dione
4-(1-hydroxy-3-oxobutyl)-5-(3-methoxy-2-methyl-5-oxocyclopent-1-en-1-yl)-3-methylideneoxolan-2-one
7-hydroxy-8-(3-methylbut-1-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
8,9-dihydroxy-3-methoxy-6,12,12-trimethyl-5,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-4-one
(8e)-4-methoxy-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,8,15,18-heptaen-12-one
(2r,3r,4s,5s,6r)-2-[(2e,8z)-deca-2,8-dien-4,6-diyn-1-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol
n-[2-(2,2-dimethylchromen-6-yl)ethyl]pyridine-3-carboximidic acid
ethyl 2-[(2s)-7-hydroxy-2-[(2s)-2-hydroxypropyl]-4-oxo-2,3-dihydro-1-benzopyran-5-yl]acetate
(3s,4as,10r,10ar)-3,10-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h,4ah,10h,10ah-naphtho[2,3-c]pyran-5-one
(3r,4ar,10s,10as)-3,10-dihydroxy-7,9-dimethoxy-3-methyl-1h,4h,4ah,10h,10ah-naphtho[2,3-c]pyran-5-one
2-methoxy-4-{[5-(2-phenylethyl)furan-2-yl]methyl}phenol
(3s,4ar,5s,10as)-5,9-dihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
5-methyl-9-(3-methylbut-2-en-1-yl)-10h-phenazine-1-carboxylic acid
2-(hydroxymethyl)-6-[(2,5,6-trihydroxycyclohex-3-en-1-yl)oxy]oxane-3,4,5-triol
{4-[5-methyl-5-(2-methylbutyl)furan-2-ylidene]-3,5-dioxooxolan-2-yl}acetic acid
(2s,3r,4r,5s)-6-(acetyloxy)-4-hydroxy-1,3,5-trimethoxyhexan-2-yl acetate
9,10-dihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,10h,10ah-naphtho[2,3-c]pyran-5-one
2-formyl-3-(hydroxymethyl)-6-methoxy-5-methyl-4-[(3-methylbut-2-en-1-yl)oxy]benzoic acid
2,7-dihydroxy-3,6,9-trimethyl-4-(2-methylprop-1-en-1-yl)phenalen-1-one
(6s,15s)-5,14-dihydroxy-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione
C14H20N4O4 (308.14844800000003)
(2r,3r,4s,5s,6r)-2-(deca-2,8-dien-4,6-diyn-1-yloxy)-6-(hydroxymethyl)oxane-3,4,5-triol
8-[(2s)-2,3-dihydroxy-3-methylbutyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
(3r)-5,6,8-trihydroxy-3-{[(2r,6s)-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
(6s,7r,8ar,10r,10ar)-1,6,7,10-tetrahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
5-(4-methoxyphenyl)-6,7-dimethyl-2h,5h,6h-naphtho[2,3-d][1,3]dioxole
7,12,14-trihydroxy-3-methyl-4,5,6,7,8,10-hexahydro-3h-2-benzoxacyclododecine-1,9-dione
(2s,3r,4as,9as,10r)-2,3,5,10-tetrahydroxy-7-methoxy-2-methyl-1,3,4,4a,9a,10-hexahydroanthracen-9-one
4-{3-[(acetyloxy)methyl]oxiran-2-yl}-2-methoxyphenyl 2-methylpropanoate
9-hydroxy-7-methoxy-11,11-dimethyl-4bh,10h,10ah-benzo[b]fluoren-5-one
hydroxy({[(3s,6s)-6-hydroxy-4,7,7-trimethyl-1-oxo-3h,6h,8h-indeno[4,5-c]furan-3-yl]methoxy})oxoazanium
(1s,7r,8r,9s,12s,16r)-7,8-dihydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadec-2-ene-4,11-dione
(4s)-8,11,13-trihydroxy-4-methyl-4,5,6,7,8,9-hexahydro-1h-3-benzoxacyclododecine-2,10-dione
7-[(3r)-6,8-dihydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]heptanoic acid
7-(2-hydroxy-3-methoxy-3-methylbutoxy)-6-methoxychromen-2-one
2-(1,4-dihydroxycyclohexyl)-5-hydroxy-7-methoxy-2,3-dihydro-1-benzopyran-4-one
2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
6,8-dihydroxy-3-[(5-hydroxy-6-methyloxan-2-yl)methyl]-3,4-dihydro-2-benzopyran-1-one
(2s,4r,6s)-10-hydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
(3r)-6,8-dihydroxy-3-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
7-(6,8-dihydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)heptanoic acid
(3ar,4r,7r,9r,9ar,9br)-4,7-dihydroxy-9-methoxy-6,9-dimethyl-3-methylidene-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2,8-dione
(2s,3r,4s,5s)-6-(acetyloxy)-3-hydroxy-1,4,5-trimethoxyhexan-2-yl acetate
6-[(5e)-3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl]-4-methoxypyran-2-one
methyl 2-[(4ar,5r,6r,7s,8as)-8a-ethenyl-5,7-dihydroxy-4-methylidene-3-oxo-hexahydro-2-benzopyran-6-yl]prop-2-enoate
7-hydroxy-5,6-dimethoxy-3-(3-oxohexyl)-3h-2-benzofuran-1-one
3-[(2r,4s)-2,4-dihydroxyheptyl]-6,8-dihydroxyisochromen-1-one
methyl (3s,5s)-5-hydroxy-3-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]hexanoate
methyl 3,11-dihydroxy-7,8,10-trimethyl-2,6-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),9,11-triene-3-carboxylate
2-{2-[(acetyloxy)methyl]oxiran-2-yl}-5-(hydroxymethyl)phenyl 2-methylpropanoate
9-(4-hydroxy-3-methylbut-2-en-1-yl)phenazine-1-carboxylic acid
(3s)-7-hydroxy-5,6-dimethoxy-3-(3-oxohexyl)-3h-2-benzofuran-1-one
butyl 3-(7,8-dihydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)propanoate
(3s,6s)-8,9-dihydroxy-3-methoxy-6,12,12-trimethyl-5,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-4-one
(5s,7s,8ar,10s,10as)-1,4,5,7-tetrahydroxy-10-methoxy-2-methyl-6,7,8,8a,10,10a-hexahydro-5h-anthracen-9-one
3,11-dihydroxy-3,7,8,10-tetramethyl-2,6-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),9(13),10-triene-12-carboxylic acid
3-methoxy-2-(methoxycarbonyl)-4-methyl-5-[(3-methylbut-2-en-1-yl)oxy]benzoic acid
(3s,5s,7r,8s)-3,11-dihydroxy-3,7,8,10-tetramethyl-2,6-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),9(13),10-triene-12-carboxylic acid
(2s)-7-hydroxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
2-(3,4-dimethoxyphenyl)-3-methyl-5-(prop-1-en-1-yl)-1-benzofuran
6-(2,3-dihydroxy-3-methylbutyl)-5,7-dimethoxychromen-2-one
(3s,5r)-5,9-dihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
8-(2,3-dihydroxy-3-methylbutyl)-5,7-dimethoxychromen-2-one
4,7-dihydroxy-9-methoxy-6,9-dimethyl-3-methylidene-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2,8-dione
4-[(2r,3r)-3-[(acetyloxy)methyl]oxiran-2-yl]-2-methoxyphenyl 2-methylpropanoate
(2s,5s,6r,7s,9s)-9-hydroxy-5,9,13-trimethyl-4-oxo-3,12-dioxatricyclo[8.3.0.0²,⁶]trideca-1(13),10-dien-7-yl acetate
(2r,3s,4r,5s)-2-[(2,2-dimethylchromen-6-yl)oxy]-5-(hydroxymethyl)oxolane-3,4-diol
1-{2-hydroxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-phenylprop-2-en-1-one
8,11,13-trihydroxy-4-methyl-4,5,6,7,8,9-hexahydro-1h-3-benzoxacyclododecine-2,10-dione
(3r,6r)-8,9-dihydroxy-3-methoxy-6,12,12-trimethyl-5,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-4-one
7,8-dihydroxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadec-2-ene-4,11-dione
(2s)-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2r,3s,4s,5r)-2-[(2,2-dimethylchromen-6-yl)oxy]-5-(hydroxymethyl)oxolane-3,4-diol
3-hydroxy-5-[1-(5-hydroxy-3-methyl-4-oxo-5h-furan-2-yl)propan-2-yl]-4-methyl-5-(prop-1-en-1-yl)furan-2-one
8-[(3s)-4-hydroxy-3-methylbutoxy]-5,7-dimethoxychromen-2-one
8-[(2s)-2,3-dihydroxy-3-methylbutyl]-5,7-dimethoxychromen-2-one
(2s)-5-hydroxy-7-methoxy-2-[(1s,4r)-1,4-dihydroxycyclohexyl]-2,3-dihydro-1-benzopyran-4-one
butyl 3-[(3r)-7,8-dihydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]propanoate
(3r)-1-(4-methoxy-1-benzofuran-5-yl)-3-phenylpentan-1-one
1-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one
(4s,5s,8s,9z)-9-ethylidene-5,8-dihydroxy-4-propyl-4h,5h,7h,8h,10h-cyclonona[c]furan-1,3,6-trione
(3s)-6,8-dihydroxy-3-{[(2r,5r,6s)-5-hydroxy-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
6-[(2s)-2,3-dihydroxy-3-methylbutyl]-5,7-dimethoxychromen-2-one
6-(3,5-dimethyl-6-phenylhexa-1,3,5-trien-1-yl)-4-methoxypyran-2-one
9-(3-hydroxy-3-methylbut-1-en-1-yl)phenazine-1-carboxylic acid
(2s,4s,6r)-10-hydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carboximidic acid
[(2r)-4-[(2z,5r)-5-methyl-5-[(2r)-2-methylbutyl]furan-2-ylidene]-3,5-dioxooxolan-2-yl]acetic acid
(1r,3r,4s)-6,8-dihydroxy-3,4,5-trimethyl-1-(2-oxopropyl)-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid
(5s,6r)-5-(4-methoxyphenyl)-6,7-dimethyl-2h,5h,6h-naphtho[2,3-d][1,3]dioxole
(4s,8s)-8,11,13-trihydroxy-4-methyl-4,5,6,7,8,9-hexahydro-1h-3-benzoxacyclododecine-2,10-dione
ethyl 2-[7-hydroxy-2-(2-hydroxypropyl)-4-oxo-2,3-dihydro-1-benzopyran-5-yl]acetate
(3r,7r)-7,12,14-trihydroxy-3-methyl-4,5,6,7,8,10-hexahydro-3h-2-benzoxacyclododecine-1,9-dione
ethyl 2-[(2r)-7-hydroxy-2-[(2s)-2-hydroxypropyl]-4-oxo-2,3-dihydro-1-benzopyran-5-yl]acetate
[(2r)-4-[(2z,5s)-5-methyl-5-[(2s)-2-methylbutyl]furan-2-ylidene]-3,5-dioxooxolan-2-yl]acetic acid
5-(1-chlorohex-3-en-5-yn-1-yl)-2-(penta-1,3-dien-1-yl)oxolan-3-yl acetate
C17H21ClO3 (308.11791460000006)